Pooled Data Show Benefits of Cladribine Tablets on Relapse Rates and Disability Progression in Patients With MSMay 25, 2017Multiple Sclerosis
Preliminary Results Suggest Ublituximab Is Safe in Relapsing Multiple Sclerosis May 25, 2017Multiple Sclerosis
MRI Lesion Activity and Relapses May Predict Short- and Long-Term Outcomes in MSMay 25, 2017Multiple Sclerosis
